Compare Enveric Biosciences Inc (ENVB) vs Ross Stores, Inc. (ROST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Ross Stores, Inc. — how do they compare? Enveric Biosciences Inc trades at $1.51 (market cap $6.69M), while Ross Stores, Inc. trades at $226 (market cap $72.05B). The key difference: Ross Stores, Inc. is far larger — about 10769.8× Enveric Biosciences Inc's market cap, and Ross Stores, Inc. pays a 0.79% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Enveric Biosciences Inc for 14 Days and Ross Stores, Inc. for 48 Days on average.
| ENVB | ROST | |
|---|---|---|
Market Cap | $6.69M | $72.05B |
Volume | 41,141 | 1,674,861 |
Sector | Health | Consumer Cyclical |
52-Week High | $10.80 | $255.23 |
52-Week Low | $1.27 | $147.71 |
Typical Hold Time | 14 Days | 48 Days |
Enterprise Value | -$1.60M | $72.50B |
Dividend Yield | — | 0.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.495, up 1.7% on the day, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The company reported no revenue in 2025 and a net loss of $8.77 million, though it has consistently beaten EPS expectations. Recent news includes a new U.S. patent allowance for its non-hallucinogenic mescaline derivatives and participation in an investment conference.
The outlook remains speculative given the lack of revenue and negative profitability, but analyst consensus is bullish with 75% buy ratings. Key risks include the pre-revenue biotech model and dependence on successful drug development. Upside potential hinges on clinical progress and regulatory milestones for its psychiatric therapeutics pipeline.
Ross Stores (ROST) trades at $225.20, up 0.44% today, showing strong fundamental performance with consistent earnings beats and robust profitability metrics including 42.63% ROE and 10.85% net margin. The stock faces technical headwinds with a bearish signal from moving averages, trading near support at $224. Recent news highlights store expansion initiatives and strong closeout supply benefits as the company captures value-conscious shoppers amid competitive retail pressures.
ROST presents a compelling investment case with analyst consensus pointing to 22% upside to the $274.14 price target, supported by strong earnings momentum and expanding margins. Key risks include retail competition, cost pressures, and macroeconomic sensitivity, but the company's value-focused strategy and operational discipline position it well for sustained growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Ross Stores, Inc.
Ross Stores is a leading American off-price apparel and home fashion retailer, operating over 1,920 stores (at the end of fiscal 2021) across the Ross Dress for Less and dd's Discounts banners. Ross offers a variety of name-brand products and targets undercutting conventional retailers' regular prices by 20%-70%. The company uses an opportunistic, flexible merchandising approach
Read more on ROST →
